Ginkgo Bioworks DNA Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's accounts receivable?
- Ginkgo Bioworks (DNA) reported accounts receivable of $19.82M in Q1 2026.
- How has Ginkgo Bioworks's accounts receivable changed year-over-year?
- Ginkgo Bioworks's accounts receivable decreased by 24.6% year-over-year, from $26.29M to $19.82M.
- What is the long-term trend for Ginkgo Bioworks's accounts receivable?
- Over 3 years (2022 to 2025), Ginkgo Bioworks's accounts receivable has grown at a -44.0% compound annual growth rate (CAGR), from $533.45M to $93.9M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.